Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| U1111-1138-8495 | Other Identifier | WHO |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study is conducted in Asia. The aim of this non-interventional study is to evaluate the current status of diabetes management, control, and complications in diabetic subjects in Sri Lanka.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Subjects with diabetes mellitus (type 2) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| No treatment given | Other | Patients will fill out a questionnaire by interview. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Proportion of patients having HbA1c ((Glycosylated Haemoglobin) as measured during survey) less than 7% | Evaluated at the first visit (only one study visit) |
| Measure | Description | Time Frame |
|---|---|---|
| Mean Fasting Plasma Glucose (FPG) of patients | Evaluated at the first visit (only one study visit) | |
| Mean Postprandial Plasma Glucose (PPG) of patients | Evaluated at the first visit (only one study visit) |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
People having been treated for at least a year are eligible for the study. The selection of the patients will be done randomly by the individual physician involved in the study.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Global Clinical Registry (GCR, 1452) | Novo Nordisk A/S | Study Director |
Not provided
Not provided
| Label | URL |
|---|---|
| Clinical Trials at Novo Nordisk | View source |
Not provided
Not provided
Not provided
Not provided
| Mean HbA1c of patients | Evaluated at the first visit (only one study visit) |
| Proportion of patients having dyslipidemia | Evaluated at the first visit (only one study visit) |
| Proportion of patients having hypertension | Evaluated at the first visit (only one study visit) |
| Proportion of patients having cardiovascular complications | Evaluated at the first visit (only one study visit) |
| Proportion of patients having peripheral vascular disease | Evaluated at the first visit (only one study visit) |
| Proportion of patients having diabetic nephropathy | Evaluated at the first visit (only one study visit) |
| Proportion of patients having diabetic eye complications | Evaluated at the first visit (only one study visit) |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
| D004700 | Endocrine System Diseases |
Not provided
Not provided